Likewise, HCC patients with stages III + IV showed a significant increase in the expression levels of PRMT3, PRMT4, and PRMT5 compared to those with stage I. Conversely, no notable differences were observed in the expression levels of PRMT6, PRMT7, and PRMT9. The gene discussed is PRMT9; the disease is hepatocellular carcinoma.